Evidence map›Paper›PMID 12719981›Full record

ReviewPflugers Archiv : European journal of physiology2004

Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.

Nian-Hang Chen, Maarten E A Reith, Michael W Quick

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 1 synthesis or guideline pooled it, 411 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Control of Conformational Transitions by the Conserved GXInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nian-Hang ChenDepartment of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine, Peoria, Illinois, USA.
Maarten E A Reith
Michael W Quick
Illinois College · USUniversity of Southern California · US

Funding

The dopamine transporter and ions, substrates, blockersR01DA013261 · NIDA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REITH, MAARTEN E · 2000 to 2010
$2.4M
GABA Transporters: Trafficking and RegulationR01DA010509 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI QUICK, MICHAEL W. · 2001 to 2005
$1.4M
GABA TRANSPORTER INTERACTING DOMAINSR01MH061468 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI QUICK, MICHAEL W. · 2000 to 2004
$1.2M
COCAINE AND REGULATION OF THE DOPAMINE TRANSPORTERR01DA011978 · NIDA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REITH, MAARTEN E · 2000 to 2003
$899k
AMINE TRANSPORTERS--TRAFFICKING AND REGULATIONR29DA010509 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI QUICK, MICHAEL W. · 1996 to 2000
$108k
NIDA NIH HHS DA10509NIDA NIH HHS DA11978NIDA NIH HHS DA13261NIMH NIH HHS MH61468
6 · The paper itself

Abstract

The SLC6 family is a diverse set of transporters that mediate solute translocation across cell plasma membranes by coupling solute transport to the cotransport of sodium and chloride down their electrochemical gradients. These transporters probably have 12 transmembrane domains, with cytoplasmic N- and C-terminal tails, and at least some may function as homo-oligomers. Family members include the transporters for the inhibitory neurotransmitters GABA and glycine, the aminergic transmitters norepinephrine, serotonin, and dopamine, the osmolytes betaine and taurine, the amino acid proline, and the metabolic compound creatine. In addition, this family includes a system B(0+) cationic and neutral amino acid transporter, and two transporters for which the solutes are unknown. In general, SLC6 transporters act to regulate the level of extracellular solute concentrations. In the central and the peripheral nervous system, these transporters can regulate signaling among neurons, are the sites of action of various drugs of abuse, and naturally occurring mutations in several of these proteins are associated with a variety of neurological disorders. For example, transgenic animals lacking specific aminergic transporters show profoundly disturbed behavioral phenotypes and probably represent excellent systems for investigating psychiatric disease. SLC6 transporters are also found in many non-neural tissues, including kidney, intestine, and testis, consistent with their diverse physiological roles. Transporters in this family represent attractive therapeutic targets because they are subject to multiple forms of regulation by many different signaling cascades, and because a number of pharmacological agents have been identified that act specifically on these proteins.

Indexed as

Biological TransportChloridesHumansMembrane Transport ProteinsMultigene FamilyNeurotransmitter AgentsSodiumSynapsesChloridesMembrane Transport ProteinsNeurotransmitter AgentsSodium

Identifiers

PMID12719981
OpenAlexW2039923977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.